Eating Disorder Examination Questionnaire required for Medicare items for some patients

Dear Users,
The new Eating Disorder Medicare items are great news for patients in need of assistance, but there are lots of questions about the conditions of this new funding and how patients can access it. The APS has done a fabulous job outlining who is eligible, and one of the criteria includes a score on the Eating Disorder Examination Questionnaire (EDE-Q) above 3.

We are pleased to announce that as a user of NovoPsych you can now administer the Eating Disorder Examination Questionnaire to your patients, where scores are automatically calculated and graphed by the software.

Given that EDE-Q scores make up one component of the Medicare eligibility criteria, including a copy of the completed scale while corresponding with referring GPs will be a useful way of communicating symptom severity. 

Below is some information to familiarise yourself with the scale. I’d also suggest logging into NovoPsych and doing a practice administration on yourself.
Login to NovoPsych
EDE-Q Quick Summary
Used with: Adolescents and Adults
Measures:  Eating Disorder symptoms (Anorexia, Bulimia, Binge Eating Disorder, EDNOS)
Helpful for: Screening for Eating Disorders and tracking symptoms over time

Eating Disorder Examination Questionnaire (EDE-Q 6.0)
The Eating Disorder Examination Questionnaire (EDE-Q) is a self-report questionnaire that measures the frequency of thoughts and behaviours related to eating disorders in the past 28 days. It has four subscales: restraint, eating concern, shape concern and weight concern, as well as behavioural symptoms related to these concerns (e.g., frequency of binge eating, vomiting, use of laxatives or diuretics and overexercise). It is appropriate for use with adolescents and adults in primary care settings as a screener for eating disorders (Anorexia, Bulimia, Binge Eating Disorder and EDNOS).
Scores are presented as an average score (between 0 and 6), where 0 represents “No Days” of eating disorder symptoms and 6 represents symptoms “Everyday”.

Percentiles are also presented related to a normative female sample (Mond et al., 2006). A percentile of 50 represents typical eating and body image concerns among adult women while scores above the 85th percentile are considered to be of clinical significance. An Eating Disorder Percentile is also presented for the Global score, where a percentile of 50 is indicative of average scores for those independently diagnosed with an eating disorder (AN, BN, BED or EDNOS) (Aardoom, et al., 2012).

The literature indicates a Global Score clinical cut-off of 2.8 for women (Mond et al., 2015) and 1.68 for men (Schaelfer et al., 2018), however in Australia scores above 3 contributes to eligibility for eating disorder MBS items.

To get more information about the assessment visit here, or by logging into your NovoPsych account.
Login to view full details
Dr Ben Buchanan
BA (Hons), GradDipPsych, DPsych, MAPS
Co-founder & Director of NovoPsych Pty Ltd

Fairburn, Christopher G. Cognitive behavior therapy and eating disorders. Guilford Press, 2008.

Assess patient’s mental health remotely via email

The majority of clinicians choose to administer psychometric questionnaires face-to-face in session via the NovoPsych iPad app, however more practices are getting digital and tele-health savvy and administering questionnaires remotely. I want to show you how NovoPsych makes this possible, with features allowing assessments to be sent to your patients via email.

Clients can answer questionnaires on their smartphone or computer at home before your next session, or even before you first meet them. 

With NovoPsych you can:

  • Send a secure email from NovoPsych to your client requesting they complete an assessment (DASS-21 etc.) 
  • Once the client completes the assessment you will be alerted, with results sent directly to you.
  • You can copy an assessment URL so you can send an assessment link to your client via your own messaging system (for example in a welcome email).
  • Have the option to setup automatic emails to be sent to your client on a weekly or monthly basis so you can track symptoms over time. 

How to send an assessment 

1. Login to the NovoPsych platform in your browser (note, these features are not available in the iPad app)
2. Press Email Assessment from the home screen

3. Select a client
4. Choose the assessments you would like to send
5. Press “Copy URL”. The link to the assessment will be ready for you to paste into an email or messaging service.

6. (Optional). If you’d like NovoPsych to send the assessment on your behalf (from the secure NovoPsych email address), you can press “Administer”, which will generate an email with the assessment. You can press “Customise Email” to amend the generic email message. 

With more and more mental health consultations happening remotely this feature helps you measure key outcomes for your patients in a fast and effective way. I hope you find it useful! 

Valuing Questionaire added to NovoPsych

In clinical practice we often get in the routine of administering the same assessments, just because we’re familiar with them. This post will help you get familiar with a new test; the Valuing Questionnaire, which I’ve just added to the NovoPsych library. 

Quick Summary

Used with: Adolescents and Adults
Measures: How consistently someone is living with their values.
Helpful for: Tracking progress in Acceptance and Commitment Therapy (ACT)

Valuing Questionnaire (VQ)

The Valuing Questionnaire (VQ: Smout et al. 2014) is a 10-item self-report scale designed to measure how consistently an individual has been living with their self-determined values and is particularly helpful when administered during a course of ACT.

Values are personal principles someone has chosen to guide their behaviour. Articulation of self-defined values is a core component of ACT-like therapies, and this scale is best used in conjunction with and subsequent to this process in therapy.  The VQ measures “valuing”, which refers to actions one takes to live in accordance with values, rather than simply pleasant outcomes or satisfaction with life.

It measures two constructs:
1. Progress, defined as enactment of values, perseverance, and including clear awareness of what is personally important.

2. Obstruction, which reflects the disruption of valued living due to avoidance of unwanted experience, distraction from values by inattention to values or undue attention to distress.

Here are the 10 questions:

Scoring and Interpretation
Two subscale scores are presented, Progress and Obstruction, which typically have a negative correlation.
Progress (items, 3, 4, 5, 7,9. Range = 0 to 30).
Obstruction (items 1, 2, 6, 8, 10. Range = 0 to 30).

Scores indicative of psychological health are high scores on the Progress scale accompanied by low scores on the Obstruction scale.

As well as raw scores being presented, percentile ranks compared to an undergraduate university sample and a clinical sample are presented. A percentile of 50 on the clinical sample on each subscale represents a typical score for people presenting to outpatient psychology clinics.

When used as a monitoring tool during a course of ACT, successful treatment is indicated by increasing Progress Scores and decreasing Obstruction Scores.

Here is some sample results. The graph shows the scores changing over the course four sessions.

I hope you’ll spend some time getting to know this test, among others. More information on NovoPsych assessments can be found here.

Yours sincerely,
Dr Ben Buchanan
Smout, M., Davies, M., Burns, N., & Christie, A. (2014). Development of the valuing questionnaire (VQ). Journal of Contextual Behavioral Science, 3(3), 164-172.

Outcome measures – Good practice but should they be required?

Dear Colleagues,

I’ve noticed momentum building around Routine Outcome Monitoring. The APS and other groups are all supporting reforms to the Medicare system to include standardised outcome measures.

In order to help psychologists administer psychometric instruments I created the NovoPsych iPad app (NovoPsych.com) and we now have thousands of psychologists using it. It computes useful metrics, graphs results over time and has dozens of assessments (DASS-21, Spence Children’s Anxiety Scale, CORE-10 etc). If you’re not already involved, you can sign up for free via www.novopsych.com.

– For users of NovoPsych, I hope you might be able to use this thread to provide any feedback about how to make the tool more useful for you?

– For others, I wonder what you make of the recommendations as part of the Medicare review about mandatory Routine Outcome Monitoring? Do you agree that it is a good idea? Are you wary of it? I personally think it *could* be great, provided the requirements don’t add too much of an administrative burden, and streamlined software like NovoPsych can make the process easy. We also need to avoid a “big brother” approach.

All feedback is really useful.

Warm regards,

Dr Ben Buchanan

Productivity Commission Submission from NovoPsych

NovoPsych Productivity Commission Submission

Addressable challenges in the mental health sector

  1. The problem that funding models promote ‘activity-based’ services because the key data measured is activity, not outcomes.
  2. The highly successful Better Access initiative does not have routine outcome monitoring baked into its structure.
  3. The mental health sector has, to date, not had the same emphasis on use of technology to assist in diagnosis and recovery compared to other health fields.
  4. Collaboration between clinician and patient is key, and systems to help individuals understand and monitor their own health and self-management are currently lacking.


NovoPsych is a technology platform designed for mental health clinicians to improve the efficiency and accuracy of mental health assessments, measurement of outcomes, communication between clinicians, and help patients in self-management.

We currently have over 3000 clinicians using the platform, primarily psychologists in private practice, but also work with larger agencies integrating the system into their model of care. The popularity and wide acceptance of our software platform is attributed to the focus on understanding the needs of clinicians, and educating them about the instant and measurable benefits for patients of routine outcome monitoring.

Routine Outcome Monitoring 

Routine outcome monitoring is the regular evaluation of a patient’s treatment response during the course of treatment and provides health care professionals with information relevant to a patient’s progress. This monitoring can improve patient outcomes by enabling clinicians to detect and treat functional and psychological problems that previously may have been missed.

The monitoring is not only useful for clinician and patients themselves, but also provides an opportunity for treatment effectiveness to be evaluated at a systemic level.

Psychologists have specific training in this area on how to interpret outcome measures and understand how to evaluate such measures’ psychometric properties for appropriate use. This is a core skill of psychologists that is under-utilized in the current system.

While state based funded mental health services collect and report on outcome data through the Australian Mental Health Outcomes and Classification Network (AMHOCN) there is no such collection of outcome data being undertaken in MBS funded Better Access services. This was identified as a gap in the initial evaluation of the initiative and considering the significant level of investment in primary mental health care it remains a major gap in the collection of data to inform service planning and the effectiveness of funded services. While many clinicians regularly collect such data using NovoPsych as part of their clinical practice, outcomes measurement is not currently a requirement of the Medicare Benefits Schedule items.

Using Data Analytics to Improve Care

Advances in data analytics and computing power mean that large datasets are an important resource in the decision making process. The best datasets are generally those that are routinely collected by clinicians as a core part of practice– but contain enough detail for researchers and funders to use for valuable secondary analysis.

It is possible to use these datasets to understand trends, patterns and correlations at a large scale and investigate a range of questions much more rapidly and cost-effectively than using methods such as surveys and clinical trials alone. Not only this, datasets can be used to predict with a high degree of accuracy the progression of illness, and therefore what interventions/funding would be optimal.

The wealth of high quality longitudinal data collected by NovoPsych (over 200 million pieces of health information for over 150,000 patients) provides an opportunity to undertake an evaluation of programs and design systems to provide people the best care in a real-time, evidence-based way. Rather than funding models where “one size fits all”, this health data system could be used to provide objective triggers for staged care.

Reducing the strain on Australia’s mental healthcare system requires finding novel approaches to sustainable healthcare delivery. Key to this is investing in a mental healthcare environment that predicts, prevents and delays the onset of chronic and long-term dysfunction, eliminates low-value care and has the capacity to scrutinize and adjust funding in a timely way.

It is urgent that funding systems be person centric, have a degree of precision in the likely outcomes of treatment, and be able to measure the outcome of treatment reliably.

Yours Sincerely,

Dr Ben Buchanan

Co-Founder and Director



A Self‐Report Survey: Australian Clinicians’ Attitudes Towards Progress Monitoring Measures. Australian Psychologist.

Chun, J., Buchanan, B (2018) A Self‐Report Survey: Australian Clinicians’ Attitudes Towards Progress Monitoring Measures. Australian Psychologist. https://onlinelibrary.wiley.com/doi/abs/10.1111/ap.12352


Research supports an association between regularly administering standardised measures to assess client progress (progress monitoring) and improved treatment outcomes. However, some research suggests clinicians often rely heavily and solely on clinical judgement when making treatment decisions. This study was the first to explore psychologists’ implementation of progress monitoring, within an Australian clinical context.

A self‐report survey investigated Australian psychologists’ (N = 208; gender and age proportional to national representation) attitude, awareness, use, motives, and barriers towards implementing standardised assessment and progress monitoring. The survey comprised of the Attitudes towards Standardised Assessment Scales, and existing literature on progress monitoring implementation.

Ninety‐eight per cent of psychologists were aware of progress monitoring measures, and 69% reported using them in practice. Majority of progress monitoring users rated these measures as very useful (51%) and over one third (39%) used them with most of their clients. Contrary to the hypothesis, a t‐test demonstrated that attitude towards standardised assessment did not differ between progress monitoring users and non‐users. Among the clinicians who have not implemented progress monitoring, time barriers were rated as most important.

This study demonstrates that although awareness of progress monitoring may be widely known, perceived barriers may outweigh the potential benefits for some. It is also concluded that further qualitative research is needed to adequately understand these barriers and their importance. Future interventions may then promote evidence‐based recommendations and focus on the practicality, utility, and workflow difficulties associated with incorporating progress monitoring.

Clinician views of client self-monitoring

Article punished in InPsych Magazine, August 2018. 

The regular use of standardised self-assessment and progress monitoring forms has been associated with improved client treatment outcomes. Research suggests that clinical judgment alone may not be the most accurate and effective method of predicting deterioration in client wellbeing or progress. Progress monitoring forms can be administered at regular intervals during therapy and provide ongoing, individualised and immediate client feedback. Australian researchers surveyed psychologists (N=208) about their attitudes towards using such forms with clients. About half of the psychologists surveyed found such forms useful, and 69 per cent of psychologists were using them with clients. This is in contrast with similar past surveys and with research suggesting that only 12 to 33 per cent of North American psychologists regularly use structured tools with clients. The researchers suggested that in Australia there is increased awareness of their usefulness and emphasis placed on practical- and evidence-based recommendations by government and funding regimes.

It is also becoming easier to incorporate self-monitoring tools into practice, with online tools providing access to a variety of forms and in some cases quicker scoring and evaluation methods. Those Australian psychologists using self-monitoring forms believed strongly in their usefulness, particularly for tracking client progress and to determine if changes to treatment were needed.

Contrary to expectations, attitudes towards standardised assessment did not differ between psychologists who were regularly using progress monitoring forms and those who were not. Among those not using forms the main barriers to their use was believing they take too long to administer and score and would be too much of a burden on clients.

Psychologists were more likely to be using self-monitoring forms if they were primarily treating adults and working in private practice. This suggests a need to increase awareness of self-monitoring measures relevant for work with children. The researchers suggest more psychologists might use self-monitoring forms if their perceptions of their usefulness and practicality were enhanced and if they were given suggestions for workflow management.

Chun, J., Buchanan, B (2018) A Self‐Report Survey: Australian Clinicians’ Attitudes Towards Progress Monitoring Measures. Australian Psychologist. https://onlinelibrary.wiley.com/doi/abs/10.1111/ap.12352

Introducing WebApp

Introducing WebApp


Dear valued NovoPsych users,

I’m writing to let you know of an exciting update NovoPsych has released to make administering psychometric questionnaires easier.  Thousands of psychologists and mental health clinicians are using NovoPsych daily to track client symptoms, with assessments like the:

  • Depression Anxiety Stress Scales (DASS-21 & DASS-42)
  • Kessler Psychological Distress Scale (K10)
  • Generalised Anxiety Disorder Assessment (GAD-7)
  • Spence Children’s Anxiety Scale (SCAS)
  • And many more (see here)

And you’ve always been able to administer these via NovoPsych on an iPad, but I wanted to make that possible even when your iPad isn’t available. Now you can, with the NovoPsych WebApp, available on any smart device! Because the WebApp uses your web browser, you can use it on your laptop, Android, phone, or whatever.

And best of all, if you already have a NovoPsych account there is no cost to start using the WebApp now!

Sign into WebApp with existing account now

With the WebApp, you can send the assessment from your laptop to your client’s phone in under a second, for them to complete in the waiting room, your office, or while they’re at home. Get the results back on your laptop as soon as they’re done. 


Learn more about the WebApp

Please take a moment to watch the three minute video below that I’ve put together. It will show you how NovoPsych reduces paperwork and has helped clinicians better track client outcomes. 


I hope you find it helpful. I’m constantly trying to create a better tool to make your practice more efficient, so feel free to get in touch, give feedback or request a feature.

Yours sincerely,

Dr Ben Buchanan
Co-founder & Director of NovoPsych Pty Ltd
BA (Hons), GradDipPsych, DPsych, MAPS

Start Exploring NovoPsych Now


For North American users

Upgrade your NovoPsych account to BetterMind

Dear North American NovoPsych users,

We write to inform you that the NovoPsych app is transitioning to an upgraded platform called BetterMind by BetterWorld Healthcare, Inc. As a user of NovoPsych in North America you will be able to upgrade to the new BetterMind app for free for the next seven days. Your user account and existing client data can easily be migrated to the upgraded platform.
We thank you for being a NovoPsych user and strongly encourage you to migrate to BetterMind, which will have the following benefits:

  • BetterMind is an enhanced version of NovoPsych, helping you administer a wide range of psychometric tests via your iPad
  • BetterMind has added three more scales, totaling 43 at this time, and as part of the free migration to BetterMind you will enjoy use of the additional scales as well.
  • BetterMind will continue to be expanded, enhanced and fully supported.
  • You can download BetterMind for FREE (if you don’t download within 7 days of receiving this email the normal price is $29.99)

Please be aware that NovoPsych will not be providing technical support to North American users or providing app updates. As an example, the recent iOS 11 update was done for BetterMind but not done for NovoPsych in North America.  This means that the NovoPsych App will not be supported in North America and the App may eventually stop working.  As a result, you are strongly encouraged to transfer your account to BetterMind.

Once again, we thank you for being a NovoPsych user.  We are confident you will continue to enjoy the same benefits and more using the new BetterMind App.

For any enquires please email us at Support@betterworldhealthcare.com

The NovoPsych Team